Iran, Islamic Republic of vs Lower middle income: Immunization, HepB3
Immunization, HepB3 over time
- Iran, Islamic Republic of
- Lower middle income
How they compare
Iran, Islamic Republic of currently reports 98.0% against 86.5% in Lower middle income, a difference of 11.5%.
That makes Iran, Islamic Republic of's figure about 1.1 times Lower middle income's.
Across all 31 years both countries report, Iran, Islamic Republic of has been ahead every year.
Iran, Islamic Republic of ranks 19th and Lower middle income ranks 21st of 188 countries.
Iran, Islamic Republic of has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Iran, Islamic Republic of | Lower middle income | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 81.2% | 3.4% | 77.7% | Iran, Islamic Republic of |
| 2000s | 97.2% | 29.8% | 67.4% | Iran, Islamic Republic of |
| 2010s | 98.8% | 75.4% | 23.4% | Iran, Islamic Republic of |
| 2020s | 98.6% | 84.0% | 14.6% | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Iran, Islamic Republic of or Lower middle income?
- Iran, Islamic Republic of, at 98.0% against 86.5% in Lower middle income as of 2024.
- What is the difference in immunization, hepb3 between Iran, Islamic Republic of and Lower middle income?
- 11.5%, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Lower middle income?
- 31 years are reported by both, from 1994 to 2024.
- How do Iran, Islamic Republic of and Lower middle income rank globally for immunization, hepb3?
- Iran, Islamic Republic of ranks 19th and Lower middle income ranks 21st of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.